On Saturday, August 15 from 10:00 a.m. to 11:00 a.m. (PDT), we will host a virtual support group meeting using Zoom. This is an opportunity for our community to come together in these difficult times to offer support and fellowship.
Dr. May Han and Anna Tomczak, from Stanford University, will be joining us as part of the Q & A session.
If you are planning to attend, please RSVP below to receive the login information. We are capping each meeting at a maximum of 25 attendees. The first 25 people to RSVP will receive the login information. Please check your Spam folder if you do not receive an email within 24 hours of signing up.
Here are the details for the online support group meeting that will take place from 10:00 a.m. to 11:00 a.m. on Saturday, August 15.
First, make sure your computer or phone is compatible with Zoom.
Also, please make sure you mute yourself when you are not speaking. The presenter is able to mute and unmute attendees, but it is easier if we all work together to ensure there is no background noise. Along those same lines, we recommend using headphones if possible. It helps eliminate feedback and makes it easier for attendees to hear more clearly.
Zoom allows for video and audio options. You are welcome to join via your computer and webcam device or you can simply call in via phone. There is no requirement to turn on your camera if you do not want to. If you do attend by phone, you may need to enter the Access Code provided in the login information.
We will start on time to respect everyone’s schedule. Thank you to Dr. Han, Anna, and Support Group Leader Andrea Mitchell for taking the time to join us!
If you have any questions, comments, or concerns before or during the meeting, please contact Jeremy Bennett at [email protected] and he will assist you.
SRNA Support Group Meetings are sponsored in part by
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
Viela Bio is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. Their team is comprised of passionate, talented, world-class leaders with diverse experience in the autoimmune disease space, and their research focuses on well-established critical biological pathways shared across multiple indications.
* Sponsors are not able to influence the education program.